Metabolic syndrome, sarcopenia and role of sex and age: Cross-sectional analysis of Kashiwa cohort study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Ishii, Shinya ^a   Tanaka, Tomoki ^b   Akishita, Masahiro ^a   Ouchi, Yasuyoshi ^c   Tuji, Tetsuo ^b   Iijima, Katsuya ^b   Kikutani, Takeshi ^a   Higashiguchi, Takashi ^b   Ishikawa Takata, Kazuko ^c   Obuchi, Shuichi P ^d   Shibasaki, Koji ^b   Suzuki, Masashi ^b   Oishi, Yoshiya ^e   Hirano, Hirohiko ^d   Ohara, Yuki ^d   Takahashi, Noriaki ^f   Furuya, Hiroyasu ^f   Kawai, Hisashi ^d   Mitsutake, Seigo ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^e Oishi Dental Clinic   (Japan)

^f NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; AGE; AGED; AGING; ARTICLE; CITY; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GAIT; GENDER; GRIP STRENGTH; HUMAN; JAPAN; JAPANESE (CITIZEN); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MUSCLE MASS; PREVALENCE; PROSPECTIVE STUDY; SARCOPENIA; NONPARAMETRIC TEST; OBESITY, ABDOMINAL; ODDS RATIO; SEX DIFFERENCE;

AGE FACTORS; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; ODDS RATIO; PREVALENCE; SARCOPENIA; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84912122990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112718     Document Type: Article

References (43)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
2. Romeo GR, Lee J, Shoelson SE (2012) Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 32: 1771-1776.
3. Koh KK, Han SH, Quon MJ (2005) Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 46: 1978-1985.
4. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.
5. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414.
6. Lee CG, Boyko EJ, Strotmeyer ES, Lewis CE, Cawthon PM, et al. (2011) Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc 59: 1217-1224.
7. Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, et al. (2009) Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 32: 1993-1997.
8. Schaap LA, Pluijm SM, Deeg DJ, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119: 526 e529-517.
9. Beenakker KG, Ling CH, Meskers CG, de Craen AJ, Stijnen T, et al. (2010) Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 9: 431-436.
10. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.
11. Stenholm S, Koster A, Alley DE, Houston DK, Kanaya A, et al. (2010) Joint association of obesity and metabolic syndrome with incident mobility limitation in older men and women-results from the Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci 65: 84-92.
12. Penninx BW, Nicklas BJ, Newman AB, Harris TB, Goodpaster BH, et al. (2009) Metabolic syndrome and physical decline in older persons: results from the Health, Aging And Body Composition Study. J Gerontol A Biol Sci Med Sci 64: 96-102.
13. Carriere I, Peres K, Ancelin ML, Gourlet V, Berr C, et al. (2014) Metabolic syndrome and disability: findings from the prospective three-city study. J Gerontol A Biol Sci Med Sci 69: 79-86.
14. Weiss A, Boaz M, Beloosesky Y, Kornowski R, Grossman E (2009) Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus. Diabet Med 26: 253-259.
15. Landi F, Onder G, Gambassi G, Pedone C, Carbonin P, et al. (2000) Body mass index and mortality among hospitalized patients. Arch Intern Med 160: 2641-2644.
16. Odden MC, Peralta CA, Haan MN, Covinsky KE (2012) Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 172: 1162-1168.
17. Laudisio A, Bandinelli S, Gemma A, Ferrucci L, Incalzi RA (2013) Metabolic syndrome and functional ability in older age: The InCHIANTI study. Clin Nutr. pii: S0261-5614: 00212-4.
18. Kawano Y, Ogihara T, Saruta T, Goto Y, Ishii M (2011) Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study. Am J Hypertens 24: 1250-1256.
19. Yang EJ, Lim S, Lim JY, Kim KW, Jang HC, et al. (2012) Association between muscle strength and metabolic syndrome in older Korean men and women: the Korean Longitudinal Study on Health and Aging. Metabolism 61: 317-324.
20. Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, et al. (2014) Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 14 Suppl 1: 93-101.
21. Tanimoto Y, Watanabe M, Sun W, Hirota C, Sugiura Y, et al. (2012) Association between muscle mass and disability in performing instrumental activities of daily living (IADL) in community-dwelling elderly in Japan. Arch Gerontol Geriatr 54: e230-233.
22. Nagasaki H, Itoh H, Hashizume K, Furuna T, Maruyama H, et al. (1996) Walking patterns and finger rhythm of older adults. Percept Mot Skills 82: 435-447.
23. Ainsworth BE, Bassett DR, Jr., Strath SJ, Swartz AM, O'Brien WL, et al. (2000) Comparison of three methods for measuring the time spent in physical activity. Med Sci Sports Exerc 32: S457-464.
24. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB (2008) Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 93: 3403-3410.
25. Auyeung TW, Lee JS, Kwok T, Leung J, Ohlsson C, et al. (2011) Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. Eur J Endocrinol 164: 811-817.
26. Liu PY, Beilin J, Meier C, Nguyen TV, Center JR, et al. (2007) Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab 92: 3599-3603.
27. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919; quiz 920.
28. Bucci L, Yani SL, Fabbri C, Bijlsma AY, Maier AB, et al. (2013) Circulating levels of adipokines and IGF-1 are associated with skeletal muscle strength of young and old healthy subjects. Biogerontology 14: 261-272.
29. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, et al. (2004) Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol A Biol Sci Med Sci 59: M935-939.
30. Jurca R, Lamonte MJ, Church TS, Earnest CP, Fitzgerald SJ, et al. (2004) Associations of muscle strength and fitness with metabolic syndrome in men. Med Sci Sports Exerc 36: 1301-1307.
31. Wijndaele K, Duvigneaud N, Matton L, Duquet W, Thomis M, et al. (2007) Muscular strength, aerobic fitness, and metabolic syndrome risk in Flemish adults. Med Sci Sports Exerc 39: 233-240.
32. Moon SS (2014) Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr J 61: 61-70.
33. Park SH, Park JH, Park HY, Jang HJ, Kim HK, et al. (2013) Additional role of sarcopenia to waist circumference in predicting the odds of metabolic syndrome. Clin Nutr. pii: S0261-5614: 00230-6.
34. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, et al. (2013) Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS). J Clin Endocrinol Metab 98: 811-817.
35. Lu CW, Yang KC, Chang HH, Lee LT, Chen CY, et al. (2013) Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract 7: e301-307.
36. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, et al. (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33: 1652-1654.
37. Everson-Rose SA, Paudel M, Taylor BC, Dam T, Cawthon PM, et al. (2011) Metabolic syndrome and physical performance in elderly men: the osteoporotic fractures in men study. J Am Geriatr Soc 59: 1376-1384.
38. Beavers KM, Hsu FC, Houston DK, Beavers DP, Harris TB, et al. (2013) The role of metabolic syndrome, adiposity, and inflammation in physical performance in the Health ABC Study. J Gerontol A Biol Sci Med Sci 68: 617-623.
39. Matsuzawa Y, Funahashi T, Nakamura T (2011) The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 18: 629-639.
40. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, et al. (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51: 2951-2958.
41. Despres JP (2006) Is visceral obesity the cause of the metabolic syndrome? Ann Med 38: 52-63.
42. Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93: 359-404.
43. Srikanthan P, Hevener AL, Karlamangla AS (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 5: e10805.